PNAS Nexus is fully gold open access: every published article is free to read, and there is no subscription or hybrid option. That means an article processing charge (APC) and a license choice are part of the submission, not an afterthought. This is the PNAS-Nexus-specific decision that has no analogue at flagship PNAS — and it takes the slot that the Direct/Contributed track choice occupies in the pnas-skills pack. Settle it right after pnasnexus-fit, because funding and eligibility can affect whether and how you submit.
There is no Direct vs Contributed track at PNAS Nexus. Unlike flagship PNAS, an NAS member cannot "contribute" a paper, and there is no prearranged-editor route. All submissions go through standard editor-assigned peer review (assigned to an Editorial Board member, then a handling/guest editor, with ≥2 independent reviews). If someone expects to use a member-communicated track, correct that expectation here.
| Mechanism | Who it helps |
|---|---|
| Low-income-country full waiver | Corresponding authors based in countries in OUP's low-income tier — fees fully waived. |
| Middle-income-country discount | Corresponding authors in OUP's middle-income tier — reduced APC (applied before other discounts). |
| Read & Publish / transformative agreements | Authors at institutions with an OUP agreement — the institution covers the charge. Note: you may not switch the corresponding author just to access this funding. |
| Membership discount | A membership-discount option exists in the calculator; the exact eligibility/amount is 待核实 — confirm. |
| Discretionary waiver | Authors without sufficient funds may request a waiver at submission (historically via openaccess@oup.com) — confirm the current route. |
Eligibility usually hinges on the corresponding author's affiliation/region. Decide who the corresponding author is before you price the APC — and never reassign corresponding authorship purely to capture Read & Publish funding.
PNAS Nexus offers two Creative Commons licenses (as of the February-2024 change, CC BY-NC-ND is no longer offered):
| License | What it allows | Choose it when |
|---|---|---|
| CC BY 4.0 | Anyone may reuse, including commercially, with attribution. | Your funder requires CC BY (Plan S / cOAlition S, Wellcome, UKRI, Gates, NIH 2025 public-access expectations). The safe default for compliance. |
| CC BY-NC 4.0 | Reuse with attribution, non-commercial only. | You specifically want to restrict commercial reuse and no funder mandate forbids NC. |
【OA model】 gold OA confirmed (no hybrid/subscription option)
【APC】 confirm-live via OUP calculator (category + region) — figure NOT asserted from memory
【Waiver/discount path】 LMIC full-waiver / LMIC discount / Read&Publish / membership / discretionary / none
【Corresponding author】 ___ (drives eligibility; not reassigned for funding)
【License】 CC BY 4.0 / CC BY-NC 4.0 + one-line reason
【Funder mandate】 funder(s): ___ → license/deposit requirement satisfied? yes/no
【Track reminder】 no Direct/Contributed track — standard editor-assigned review
【Next】 pnasnexus-writing